you are correct, but I would say big pharma have us on their radar. With Vinnie at the helm it’s really unlikely that they don’t. Especially now with the success of the 2a trial.
The company has for the first time confirmed CBD’s anti microbial properties and is on the bleeding edge with their research. Their IP would be much higher than the current SP and very valuable to a big pharma outfit. The 2a trial also validated acne and ros trials too.
With success in a 2b anything could happen. But for now the big boys are checking us out deciding whether to ask us to dance.
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-444
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $588.2M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.5¢ | $1.302M | 3.974M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 713153 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 215665 | 6 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |